BioSpace News Archive

Drug Development

Pneumagen Ltd Demonstrates Preclinical Proof-of-Concept for Neumifil™ in Respiratory Syncytial Virus Infections

Pneumagen Ltd announced in vivo data on its lead product, Neumifil™, generated from its proprietary GlycoTarge platform.

September 10, 2019
·
2 min read
Ground-breaking trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer

Oncimmune Holdings plc welcomes the presentation of data by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT® Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.

September 10, 2019
·
8 min read
Policy

Bactiguard’s urinary catheters approved for reimbursement in the Dutch market

Bactiguard’s indwelling urinary catheters are now approved for reimbursement in the Netherlands, which means that healthcare providers in the home care market can provide patients with Bactiguard’s products for infection prevention and improve their quality of life.

September 10, 2019
·
2 min read
Policy

Noscendo Reaches CE Certification as Key Milestone for its Proprietary Diagnostic Platform DISQVER® and Conducts Successful Piloting in Eight Maximum Care Hospitals

Bioinformatic software is the basis for development in the automated relevance-based detection of blood-stream infections

September 10, 2019
·
2 min read
Abstract on Aslan Pharmactuticals’ Varlitinib Accepted for Poster Presentation at ESMO Asia Congress 2019

ASLAN Pharmaceuticals announced that an abstract on its lead candidate, varlitinib, has been accepted for poster presentation at the ESMO Asia Congress 2019 in Singapore on 22 November – 24 November.

September 10, 2019
·
4 min read
Business

Secarna Pharmaceuticals enters into oncology research agreement with global top 10 pharmaceutical company

Secarna Pharmaceuticals announced that the Company has entered into an research agreement with a global pharmaceutical company to support research and discovery in the field of oncology.

September 10, 2019
·
3 min read
Business

DCprime Initiates Research Collaboration with the University Medical Center of Groningen on Relapse Vaccine Approach for Ovarian Cancer

DCprime Initiates Research Collaboration with the University Medical Center of Groningen on Relapse Vaccine Approach for Ovarian Cancer

September 10, 2019
·
2 min read
Policy

Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) in Tumor-Induced Osteomalacia (TIO)

Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd. announced plans to submit a supplemental Biologics License Application to the U.S. Food and Drug Administration for Crysvita® for the treatment of FGF23-related hypophosphatemia associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized.

September 10, 2019
·
8 min read
Policy

FDA Extends CRADA with CluePoints to Further Explore a Data-Driven Approach to Quality Oversight in Clinical Trials

FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research.

September 10, 2019
·
3 min read
Drug Development

MyoKardia to Evaluate Mavacamten as an Alternative to Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Patients

Planned Study Will Assess Effect of Mavacamten on the Need for SRT Among HCM Patients Referred for Invasive Procedures

September 10, 2019
·
7 min read